151 related articles for article (PubMed ID: 28056737)
1. Elucidation of the Tubulin-targeted Mechanism of Action of 9-(3-pyridyl) Noscapine.
Pradhan S; Mahaddalkar T; Choudhary S; Manhcukonda N; Nagireddy PR; Kantevari S; Lopus M
Curr Top Med Chem; 2017; 17(22):2569-2574. PubMed ID: 28056737
[TBL] [Abstract][Full Text] [Related]
2. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis of Noscapine Activation for Tubulin Binding.
Oliva MA; Prota AE; Rodríguez-Salarichs J; Bennani YL; Jiménez-Barbero J; Bargsten K; Canales Á; Steinmetz MO; Díaz JF
J Med Chem; 2020 Aug; 63(15):8495-8501. PubMed ID: 32657585
[TBL] [Abstract][Full Text] [Related]
4. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
5. Tubulin binding, protein-bound conformation in solution, and antimitotic cellular profiling of noscapine and its derivatives.
Bennani YL; Gu W; Canales A; Díaz FJ; Eustace BK; Hoover RR; Jiménez-Barbero J; Nezami A; Wang T
J Med Chem; 2012 Mar; 55(5):1920-5. PubMed ID: 22320354
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of noscapine analogues as microtubule-interfering agents.
Dai HL; Zheng JB; Lin M; Zheng J; Zhou FS; Dong XC; Guo L; Liu JW; Wen R
Yao Xue Xue Bao; 2012 Oct; 47(10):1347-57. PubMed ID: 23289148
[TBL] [Abstract][Full Text] [Related]
7. A Comprehension into Target Binding and Spatial Fingerprints of Noscapinoid Analogues as Inhibitors of Tubulin.
Mandavi S; Verma SK; Banjare L; Dubey A; Bhatt R; Thareja S; Jain AK
Med Chem; 2021; 17(6):611-622. PubMed ID: 31951171
[TBL] [Abstract][Full Text] [Related]
8. Copper(I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapine.
Manchukonda NK; Sridhar B; Naik PK; Joshi HC; Kantevari S
Bioorg Med Chem Lett; 2012 Apr; 22(8):2983-7. PubMed ID: 22425569
[TBL] [Abstract][Full Text] [Related]
9. Discovery of noscapine derivatives as potential β-tubulin inhibitors.
Nemati F; Salehi P; Bararjanian M; Hadian N; Mohebbi M; Lauro G; Ruggiero D; Terracciano S; Bifulco G; Bruno I
Bioorg Med Chem Lett; 2020 Oct; 30(20):127489. PubMed ID: 32784088
[TBL] [Abstract][Full Text] [Related]
10. Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.
Mishra RC; Karna P; Gundala SR; Pannu V; Stanton RA; Gupta KK; Robinson MH; Lopus M; Wilson L; Henary M; Aneja R
Biochem Pharmacol; 2011 Jul; 82(2):110-21. PubMed ID: 21501599
[TBL] [Abstract][Full Text] [Related]
11. Rational design, synthesis and biological evaluations of amino-noscapine: a high affinity tubulin-binding noscapinoid.
Naik PK; Chatterji BP; Vangapandu SN; Aneja R; Chandra R; Kanteveri S; Joshi HC
J Comput Aided Mol Des; 2011 May; 25(5):443-54. PubMed ID: 21544622
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
[TBL] [Abstract][Full Text] [Related]
13. In silico inspired design and synthesis of a novel tubulin-binding anti-cancer drug: folate conjugated noscapine (Targetin).
Naik PK; Lopus M; Aneja R; Vangapandu SN; Joshi HC
J Comput Aided Mol Des; 2012 Feb; 26(2):233-47. PubMed ID: 22170255
[TBL] [Abstract][Full Text] [Related]
14. Exploration of efficacy, cellular responses, and safety profile of novel 9-(3-Pyridyl) noscapine derivatives as promising anticancer candidates.
Dash SG; Kantevari S; Kumar Naik P
J Biomol Struct Dyn; 2023 Oct; ():1-13. PubMed ID: 37897183
[TBL] [Abstract][Full Text] [Related]
15. 1,3-Benzodioxole-Modified Noscapine Analogues: Synthesis, Antiproliferative Activity, and Tubulin-Bound Structure.
Yong C; Devine SM; Abel AC; Tomlins SD; Muthiah D; Gao X; Callaghan R; Steinmetz MO; Prota AE; Capuano B; Scammells PJ
ChemMedChem; 2021 Sep; 16(18):2882-2894. PubMed ID: 34159741
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel and improved antimitotic agents derived from noscapine.
Anderson JT; Ting AE; Boozer S; Brunden KR; Crumrine C; Danzig J; Dent T; Faga L; Harrington JJ; Hodnick WF; Murphy SM; Pawlowski G; Perry R; Raber A; Rundlett SE; Stricker-Krongrad A; Wang J; Bennani YL
J Med Chem; 2005 Nov; 48(23):7096-8. PubMed ID: 16279766
[TBL] [Abstract][Full Text] [Related]
17. Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine.
Nambiar N; Nagireddy PKR; Pedapati R; Kantevari S; Lopus M
Life Sci; 2020 Oct; 258():118238. PubMed ID: 32791146
[TBL] [Abstract][Full Text] [Related]
18. 9-PAN promotes tubulin- and ROS-mediated cell death in human triple-negative breast cancer cells.
Verma P; Nagireddy PKR; Prassanawar SS; Nirmala JG; Gupta A; Kantevari S; Lopus M
J Pharm Pharmacol; 2020 Nov; 72(11):1585-1594. PubMed ID: 32959391
[TBL] [Abstract][Full Text] [Related]
19. Novel third-generation water-soluble noscapine analogs as superior microtubule-interfering agents with enhanced antiproliferative activity.
Henary M; Narayana L; Ahad S; Gundala SR; Mukkavilli R; Sharma V; Owens EA; Yadav Y; Nagaraju M; Hamelberg D; Tandon V; Panda D; Aneja R
Biochem Pharmacol; 2014 Nov; 92(2):192-205. PubMed ID: 25124704
[TBL] [Abstract][Full Text] [Related]
20. Potent anti-inflammatory activity of novel microtubule-modulating brominated noscapine analogs.
Zughaier S; Karna P; Stephens D; Aneja R
PLoS One; 2010 Feb; 5(2):e9165. PubMed ID: 20161797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]